GDF2 Antikörper (AA 300-429)
-
- Target Alle GDF2 Antikörper anzeigen
- GDF2 (Growth Differentiation Factor 2 (GDF2))
-
Bindungsspezifität
- AA 300-429
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GDF2 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Growth/differentiation factor 2 protein (300-429AA)
- Isotyp
- IgG
- Top Product
- Discover our top product GDF2 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- GDF2 (Growth Differentiation Factor 2 (GDF2))
- Andere Bezeichnung
- GDF2 (GDF2 Produkte)
- Synonyme
- bmp9 antikoerper, BMP-9 antikoerper, BMP9 antikoerper, Bmp9 antikoerper, DSL1 antikoerper, growth differentiation factor 2 antikoerper, gdf2 antikoerper, GDF2 antikoerper, Gdf2 antikoerper
- Hintergrund
-
Background: Potent circulating inhibitor of angiogenesis. Could be involved in bone formation. Signals through the type I activin receptor ACVRL1 but not other Alks. Signaling through SMAD1 in endothelial cells requires TGF-beta coreceptor endoglin/ENG.
Aliases: GDF2 antibody, BMP9Growth/differentiation factor 2 antibody, GDF-2 antibody, Bone morphogenetic protein 9 antibody, BMP-9 antibody
- UniProt
- Q9UK05
- Pathways
- Transition Metal Ion Homeostasis
-